KNBIF (Kane Biotech) Pre-Tax Income: $-1.69 Mil (TTM As of Mar. 2026)


What is Kane Biotech Pre-Tax Income?

Kane Biotech KNBIF +6.51% Pre-Tax Income is $-1.69 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Pretax income is the income that a company earns before paying income taxes. Kane Biotech's pretax income for the three months ended in Mar. 2026 was $-0.52 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.69 Mil. Kane Biotech's pretax margin was -1,670.97%.

During the past 13 years, Kane Biotech's highest Pretax Margin was -56.67%. The lowest was -4003.45%. And the median was -652.73%.

Kane Biotech  (OTCPK:KNBIF) Pre-Tax Income Explanation

Kane Biotech's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.518/0.031
=-1,670.97%

During the past 13 years, Kane Biotech's highest Pretax Margin was -56.67%. The lowest was -4003.45%. And the median was -652.73%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Pre-Tax Income Related Terms

Kane Biotech Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Pre-Tax Income Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.79 -2.96 -3.40 -3.14 -2.05

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.85 -0.26 -0.44 -0.48 -0.52

KNBIF vs VRTX, REGN, ALNY: Pre-Tax Income Comparison

For the Biotechnology subindustry, Kane Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech Pre-Tax Income vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Kane Biotech's Pre-Tax Income falls into.


Kane Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Kane Biotech's Pretax Income for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.924+0.035+-0.176+0.014+0
=-2.05

Kane Biotech's Pretax Income for the quarter that ended in Mar. 2026 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.491+0.012+-0.042+0.002+0.001
=-0.52

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of $-1.69 Mil mean?
Kane Biotech (KNBIF) has a Pre-Tax Income of $-1.69 Mil as of Mar. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Kane Biotech and its competitors.
Is Kane Biotech's Pre-Tax Income too high?
Kane Biotech's current Pre-Tax Income is $-1.69 Mil.
How does Kane Biotech's Pre-Tax Income compare to VRTX and REGN?
Kane Biotech's Pre-Tax Income of $-1.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Kane Biotech and its competitors. Kane Biotech's current Pre-Tax Income is $-1.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Pre-Tax Income of $-1.69 Mil. The current Pre-Tax Income is $-1.69 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Pre-Tax Income is $-1.69 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.